Showing results (1351-1360 of 2,818) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|March 6, 2024
Hybrid Closed Loop Systems Improve Glycemic Control and Quality of Life in Historically Minoritized Youth with DiabetesBrynn E Marks, Jody B Grundman, Seema Meighan, et al.Diabetes Technology & Therapeutics|March 8, 2024
Development of Machine Learning Models for the Identification of Elevated Ketone Bodies During Hyperglycemia in Patients with Type 1 DiabetesSimon Lebech Cichosz, Clara BenderDiabetes Technology & Therapeutics|March 7, 2024
A Scalable Application of Artificial Intelligence-Driven Insulin Titration Program to Transform Type 2 Diabetes ManagementMark Warren, Richard M Bergenstal, Matthew Hager, et al.Diabetes Technology & Therapeutics|March 5, 2024
Impact of an Advanced Hybrid Closed-Loop System on Glycemic Control Throughout the Menstrual Cycle in Women with Type 1 Diabetes Prone to HypoglycemiaAlex Mesa, Clara Solà, Irene Vinagre, et al.Diabetes Technology & Therapeutics|February 1, 2024
Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 DiabetesHalis Kaan AkturkDiabetes Technology & Therapeutics|January 26, 2024
Continuous Glucose Monitor Metrics Are Associated with Emergency Department Visits and Hospitalizations for Hypoglycemia and Hyperglycemia, but Have Low Predictive ValueLisa K Gilliam, Melissa M Parker, Howard H Moffet, et al.Diabetes Technology & Therapeutics|January 26, 2024
Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod® 5 Automated Insulin Delivery SystemDaniel J DeSalvo, Bruce W Bode, Gregory P Forlenza, et al.Diabetes Technology & Therapeutics|July 31, 2023
Limitations of Reporting Time Below Range as a PercentageViral N ShahDiabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.Diabetes Technology & Therapeutics|March 23, 2026
Temporal Discontinuity in Continuous Glucose Monitoring: How Midnight Segmentation Generates Systematic Measurement ArtifactMark PaullPageof 282